Daily Hong Kong Stock Market News Briefing (November 18, Monday)
Individual Stock News
-
Alibaba (09988.HK): Revenue for Q2 of fiscal year 2025 was CNY 236.503 billion, a year-on-year increase of 5%; adjusted EBITA was CNY 40.561 billion. In Q2, the company invested USD 4.1 billion to repurchase 414 million ordinary shares.
-
JD.com (09618.HK) spokesperson released a statement regarding the fire at the Wuxi logistics park: The warehouse that caught fire is an inventory warehouse, containing low-value goods.
-
CanSinoBIO (06185.HK): The company's research and development of a lyophilized b-type influenza Haemophilus influenzae conjugate vaccine has officially launched Phase I clinical trials, completing the enrollment of the first subject.
-
Youbai Online (02429.HK): The board of directors has reviewed and approved the proposal for full circulation of H shares on November 15, 2024, which involves converting 76.3197 million non-listed shares into H shares.
-
Huading Holdings (03398.HK) announced that RSM has resigned as the company's auditor, effective from November 14, 2024.
-
Junshi Biosciences (01877.HK): Toripalimab has been approved for marketing by the UK Medicines and Healthcare products Regulatory Agency.
-
Aeon (00984.HK) announced that on November 15, 2024, the company (as the tenant) signed a lease agreement for the renewal of the premises, with a fixed term of 3 years, from November 16, 2024, to November 15, 2027.
-
China Coal Energy (01898.HK) announced that in October 2024, the output of commercial coal was 11.34 million tons, a year-on-year increase of 2.3%; commercial coal sales were 25.1 million tons, a year-on-year increase of 6.7%.
-
Alibaba (09988.HK) plans to issue priority unsecured notes to repay offshore debts and for share repurchase